Similar retinitis pigmentosa (RP) phenotypes can result from mutations aVecting diVerent rhodopsin regions, and distinct amino acid substitutions can cause diVerent RP severity and progression rates. SpeciWcally, both the R135L and R135W mutations (cytoplasmic end of H3) result in diVuse, severe disease (class A), but R135W causes more severe and more rapidly progressive RP than R135L. The P180A and G188R mutations (second intradiscal loop) exhibit a mild phenotype with regional variability (class B1) and diVuse disease of moderate severity (class B2), respectively. Computational and in vitro studies of these mutants provide molecular insights into this phenotypic variability.
Introduction
RHO mutations aVecting the amino acidic sequence of the rod-speciWc protein rhodopsin are responsible primarily for autosomal dominant retinitis pigmentosa (ADRP) and account for 30-40% of this form of RP (source: RetNet: http://www.sph.uth.tmc.edu/Retnet/ disease.htm#03.202d) (RetNet-Retinal Information Network). Uncertainty remains regarding the disease severity, rate of progression, and clinical-functional phenotypes associated with speciWc RHO mutations. Accordingly, the determinants of disease expression and severity remain incompletely characterized.
Many RHO mutations have been studied in vitro, and valuable classiWcation schemes of the in vitro behavior of the mutants studied have been proposed (Kaushal & Khorana, 1994; Sung, Davenport, & Nathans, 1993; Sung, Schneider, Agarwal, Papermaster, & Nathans, 1991) . However, not all clinically relevant mutations have yet been studied, and these classiWcation schemes do not always correlate well with clinical disease expression or severity. SigniWcant progress in understanding the disease sequence and phenotypic characteristics were made when a classiWcation of rhodopsin phenotypes based on the combination of various clinical and functional criteria was developed (Cideciyan et al., 1998) . However, to date, neither has this proposed classiWcation system been corroborated by independent investigations, nor has it yet been routinely applied to families harboring other mutations.
The Wrst objective of this report is to illustrate the clinical and functional manifestations and the variability in severity and disease progression rates of RP associated with diVerent rhodopsin changes aVecting distinct portions of the molecule. We compared the following four mutations ( Fig. 1) : two distinct mutations aVecting codon 135, the arginine to tryptophan or R135W) and the argine to lysine (Arg-135-Lys, or R135L) changes, aVecting an amino acid at the cytoplasmic edge of the third rhodopsin transmembrane helix (H3); and two changes in the second intradiscal loop (E2), the proline to alanine change at codon 180 (Pro-180-Ala, or P180A) and the glycine to arginine change at codon 188 (Gly-188-Arg, or G188R).
All sequence changes have been previously associated with ADRP, but P180A has been reported only in a seemingly isolated case of RP (Sohocki et al., 2001 ). Our Wndings demonstrate that similar clinical-functional phenotypes can result from mutations aVecting diVerent regions of rhodopsin, and that distinct amino acid changes at the same codon can result in identical overall phenotypic classes but diVerent RP severity and progression rates.
Second, to test the hypothesis that these clinical Wndings could be explained at least in part by structural and functional diVerences between these mutants, and to conWrm the pathogenicity of the P180A change, computational analyses and in vitro experiments have been performed. We show that the P180A change has characteristics consistent with pathogenicity, and that misfolding and stability predictions and the corresponding characteristics experimentally observed in puriWed mutant proteins as well as their glycosylation and aggregation patterns correlate well with the gradient of severity observed among these four mutants, providing insight into the observed phenotypic variability.
Materials and methods
Data from four families (Fig. 2 ) are included in this report. Onset and type of symptoms, best corrected visual acuity to either Snellen or ETDRS charts, clinical presentation, Goldmann visual Welds, and Xash ERGs were analyzed in 16 subjects (age: 3-64). To characterize disease expression in our families, we utilized the criteria set forth by Cideciyan et al. (1998) . All procedures were conducted in accordance with the declaration of Helsinki. Blood samples were collected after obtaining signed informed consent from all subjects participating in the molecular genetic research studies, which were approved by the Institutional Review Boards of all participating institutions. Fig. 1 . Secondary structure model of rhodopsin illustrating the location of the four mutations investigated in this manuscript: R135L and R135W, aVecting the cytoplasmic edge of H3; and P180A and G188R, involving the second intradiscal loop (E2). In red and blue are highlighted the two largest clusters of mutually rigid residues belonging to the core of stability identiWed by FIRST analysis. Fig. 2 . Pedigrees of the four families investigated in this study. Arrows identify the probands from each family. The horizontal bar above the symbols correspond to examined subjects. Filled symbols identify aVected individuals. In the P180A pedigree, the half-Wlled symbol (III:1) identiWes a subject who reportedly suVered from glaucoma, and the "+" symbols indicate obesity (BMI>30).
Visual Weld and ERG recording methodology
Goldmann visual Welds to I4e and V4e targets were performed and their areas were measured in all patients using previously reported techniques (Iannaccone et al., 1995 (Iannaccone et al., , 2004 Iannaccone, 2003) . ERGs were recorded at diVerent laboratories with monopolar electrodes according to standard procedures in compliance with the ISCEV standards (Marmor, Holder, Seeliger, & Yamamoto, 2004) . The ERGs performed on the two Italian families were recorded according to methods also reported previously in detail (Del Porto et al., 1993; Iannaccone et al., 1995; Koenekoop et al., 2002; Pannarale et al., 1996; Rispoli, Iannaccone, & Vingolo, 1994) . To allow for comparison of data collected with diVerent instruments and/ or electrodes at distinct laboratories, amplitudes have been normalized as percent of the lowest limit of normal for each setting. When available, also light-(LA) and dark-adapted (DA) monochromatic automated perimetry (MAP) data were included in the analyses. The latter data were gathered according to the technique developed by Jacobson co-workers (Apáthy, Jacobson, Nghiem-Phu, Knighton, & Parel, 1987; Jacobson & Apáthy, 1988; Jacobson et al., 1986) . Further methodological details are provided in Appendix A. Normative ranges for the ERG responses recorded at UTHSC are also provided in Supplementary Table 1.
Patient population
In the Caucasian American family in which a R135L RHO mutation was identiWed (Fig. 2) , we examined a 36-year-old Caucasian male (V:3) and his symptomatic daughter (VI:2, the proband), who could be evaluated at 3, 6, and 10 years of age. In this family, there was an overt history of RP, although with no known male-to-male transmission.
The Italian family in which the R135W RHO mutation co-segregated with RP demonstrated 24 aVected individuals (Fig. 2) . Of them, 7 subjects were available for investigation (subjects IV:5, IV:9, V:7, V:8, V:10, the proband, V:13, and V:14), ranging in age from 6 to 41 years. Information of this family has been presented in part previously (Pannarale et al., 1996) .
In the African-American family harboring the P180A RHO change, two individuals were investigated (Fig. 2) , a 22-year-old male (IV:4, the proband) and his 47-year-old mother (III:2). Neither subject was aware of being aVected at the time of examination, the state of aVection having been discovered in subject IV:4 in the course of a routine eye exam following a trauma to the head region. There was, however, history of RP in this family in subjects I:2 and II:2.
Lastly, 14 aVected individuals were identiWed from the Italian family in which the G188R RHO mutation was found (Fig. 2) , 13 of whom by history. Of these, Wve were available for evaluation (III:11, IV:6, IV:10, IV:16, and IV:19, the proband). A sixth examined subject, an 8-year-old female (V:2), was asymptomatic but found to be aVected upon ERG testing. Investigated subjects from this pedigree ranged in age from 8 to 64 years. A report on the fundus features of this family has been previously published (Del Porto et al., 1993) .
Molecular genetic methods
PCR ampliWcation and sequencing of the RHO gene was performed on genomic DNA extracted from whole blood samples according to manufacturer's speciWcations with DNA QiAmp Blood Maxi kits (Qiagen, Valencia, CA) or, for the R135W and G188R families, as previously reported (Del Porto et al., 1993; Pannarale et al., 1996) . The primers used for the ampliWcation of all the Wve exons of rhodopsin have been reported before (Inglehearn et al., 1991) . The PCR ampliWcation was carried in 25 ml reaction volume using Extensor Hi-Fidelity PCR Master Mix (ABgene, Surrey, UK) according to manufacturer's instructions. The cycle conditions were 94°C for 5 min, followed by 30 cycles of 94°C for 30 s, 60C° for 30 s and 72°C for 30 s. The PCR products were treated with Exo-SAP-IT (Usb Corporation) and sequenced with Big Dye v1.1 according to manufacturer's instructions. The sequencing reaction was run on ABI Prism 3100 DNA Sequencer and the sequences were analysed with Sequencher v 4.1.4 (Gene Codes).
Computational modeling 2.4.1. Mutational data
We have recently compiled two types of experimental results for stability changes upon single-point mutations for mammalian rhodopsin (Isin, Rader, Dhiman, Klein-Seetharaman, & Bahar, 2006; Rader et al., 2004; Tastan et al., submitted) . First, the percentages of folding as deWned by the ability to bind 11-cis retinal by the mutant opsins were collected. Retinal binding was estimated from the ratio between absorbances at 280 and 500 nm. If the mutant showed at least 70% or more of the wild type (WT) reference, it was considered correctly folded. Second, the eVects on Metarhodopsin II stability as assayed by the half-life of the Xuorescence decay of light-activated rhodopsin of protein were compiled. This was done based on the assumption that factors contributing to stability of the ground state should also do so for the light-activated state. If a decrease in rate by 25% or more was observed, the mutant was considered to be more stable. If an increase in rate by 25% or more was observed, the mutant was considered to be less stable. In the case of mammalian rhodopsin, this resulted in information on 147 single-point mutations for percent folding and 159 mutations for Metarhodopsin II stability. Thus, for a total of 279 there is information related to folding and stability jointly.
Stability predictions and simulated thermal unfolding
Mammalian rhodopsin (PDB ID code: 1u19) (Okada et al., 2004 ) was used as input for stability predictions by three publicly available algorithms: I-Mutant2.0 (Capriotti, Fariselli, & Casadio, 2005) , DMU-TANT (Zhou & Zhou, 2002) , and FOLDX (Guerois, Nielsen, & Serrano, 2002) . In predictions, no distinction was made between increase and no change in stability as compared to WT. In addition, we used the FIRST software (Jacobs, Rader, Kuhn, & Thorpe, 2001 ) to make predictions of the rhodopsin folding core as previously described (Rader et al., 2004) .
In vitro experimental methodology 2.5.1. Construction of rhodopsin mutant genes
Single amino acid replacement mutants R135L, R135W, P180A, and G188R were prepared by a two-step PCR mutagenesis technique as described in the Supplementary Methods section. The primers used are also shown in Supplementary Table 2.
Cell culture and transient transfection
Transient transfection of COS-1 cells was as described (Oprian, Molday, Kaufman, & Khorana, 1987) with the exception that cells were harvested after 72 h. Proteins were puriWed by 1D4 immunoaYnity chromatography in 0.05% DM as described (Hwa, Reeves, Klein-Seetharaman, Davidson, & Khorana, 1999) . The proteins were eluted in PBS containing 70 M C-terminal nonapeptide and 0.05% (w/v) DM.
UV/Vis absorption spectroscopy
UV/Vis absorption spectra were recorded using a Perkin-Elmer Lambda 25 UV/Vis spectrophotometer with a bandwidth of 2 nm, a response time of 1 s, and a scan speed of 240 nm/min at 20°C. The molar extinction value ( 500 ) used was 40,600 M ¡1 cm ¡1 .
Deglycosylation with PNGase F
For cleavage of oligosaccharide chains from rhodopsin glycosylation sites, proteins were deglycosylated with 0.5 U/ g of rhodopsin of PNGase F (New England Biolabs). The puriWed proteins were Wrst incubated for 1 h at room temperature in denaturing buVer (0.5 M sodium phosphate, pH 7.5, 0.5% SDS, 40 mM DTT). PNGase F and 1% NP-40 were then added and the reaction mixture was further incubated for 6 h.
Polyacrylamide gel electrophoresis and immunoblotting
Protein samples were resolved by SDS-PAGE on 15% polyacrylamide-Tris vertical slab gels and transferred onto nitrocellulose membrane (Bio-Rad) according to standard protocols.
Results
The clinical and functional features of the 16 subjects included in this investigation are illustrated in detail in Supplementary Table 3 , and the overall phenotypic features associated with the four RHO mutations herein reported are summarized in Supplementary Table 4 . The following sections summarize the most salient Wndings for each mutation.
R135W and R135L: Two class A mutants resulting in diVerent disease severity and progression rates
The R135L and R135W mutations resulted in earlyonset (symptomatic and clinically visible within the Wrst decade of life, Fig. 3A and B), diVuse, and severe disease, and rod function was undetectable by ERG criteria since early childhood (class A) (Cideciyan et al., 1998) . Visual Weld loss of peripheral sensitivity and absolute constriction were already advanced by the teenage years ( Fig. 4A and B), and ERGs were severely attenuated (always <10%) at all ages ( Fig. 4C and D ). These Wndings demonstrate that the retinas of these patients do not ever develop a normal complement of rods and rod outer segments, and suggest that cone degeneration is already ongoing at birth. Our R135W patients also experienced a more severe reduction in visual acuity then those with the R135L mutation. Fig. 4E shows that the overall kinetics of ERG b-wave amplitude loss deduced from cross-sectional data appear similar between our two families, being both Wt well by logarithmic functions. However, unlike R135W patients, recordable ERGs were retained by our R135L patient through the late 30s, and their ERGs were signiWcantly larger at comparable ages. A substantially slower rate of ERG deterioration from baseline was seen in the R135L child tested serially (a progressive decline to 75% of baseline over a 7-year period, equivalent to, on average, a 3.5% yearly rate) compared to older children with the R135W mutation, in whom at a 50% year-to-year deterioration rate was documented. These longitudinal Wndings suggest also potential for faster disease progression for the R135W-associated phenotype, at least in teenage years, and for an Fig. 3 . The composites in (A and B) The ophthalmoscopic Wndings for the right and left eye, respectively, of subject VI:2 from the R135L pedigree at age 6, an example of a class A phenotype. Although bone spicule-like deposits at this young age are very sparse, they are already visible in both the nasal and temporal periphery. A moth-eaten appearance of the retinal tissue and dropout of the retinal pigment epithelium are the most prominent features and aVect both the mid-periphery in all four quadrants and the arcades. The retinal vasculature is already clearly attenuated, and waxy disc pallor is already visible, despite the high hyperopic refractive defect of this child (+8.00 sph in both eyes). At later age (not shown) prominent bone spicule-like deposits become apparent and abundant in all four quadrants, and atrophic macular changes appear in these mutants, more notably in association to the R135W mutation. This presentation contrasts strikingly with that of class B1 phenotypes, exempliWed by the proband harboring the P180A mutation (right and left eye in (C and D), respectively). The superior retina is essentially normal in appearance and so is the retinal vasculature. A sharply demarcated area of degeneration is apparent in the inferior retina, characterized by bone spicule-like deposits and whitish Xecks. In this region, mild vascular attenuation can be noted. The macular area appears free of degenerative changes.
overall resulting more severe phenotype, although it is possible that the non-linearity of the disease progression kinetics accounted for unequal rates in ERG decline at diVerent ages. Further phenotypic details are provided in Supplementary Table 3 .
P180A and G188R: Similarities and heterogeneity within class B mutants aVecting the second intradiscal loop

P180A
Unlike the Class A phenotypes, the asymptomatic proband (subject IV:4) exhibiting a C3820G RHO change, predicting the P180A amino acid substitution, had clearcut altitudinal disease at age 21 ( Fig. 3C and D) . This was accompanied by minimal superior Goldmann visual Weld loss (Fig. 5A ), essentially normal cone-mediated and only mildly abnormal rod-mediated function in the inferior hemiWeld (Fig. 5B) , and fair preservation of rod-driven, mixed, and cone-driven ERGs (black traces in Fig. 5C ). Sixteen months later, some deterioration of the ERG responses (blue traces) was observed. SpeciWcally, the mixed b-wave was 8% smaller from baseline ( Fig. 5C and  D) . In addition, progression of the disease could be inferred by the simultaneous reduction in amplitude and increased delay of the 30-Hz Xicker ERG, an increased delay in both rod-and cone-driven ERG, as well as other distinctive changes in DA responses to ¡0.31 cd s/m 2 stimuli discussed below.
The mother of the proband was also unaware of being aVected. Although she was not available for fundus photography or functional testing, she had clinical features of mild yet diVuse disease without regional predilection, which was most compatible with a class B2 phenotype (Cideciyan et al., 1998) . Of likely relevance to this intrafamilial phenotypic heterogeneity, and possibly to the sharply altitudinal disease observed in the proband, the latter had a history of unusually high exposure to sunlight for occupational reasons (farm worker). Additional phenotypic details are presented in Supplementary Table 3 .
G188R
Similar to patients with mutations aVecting codon 135, also the G188R mutation was associated with a diVuse retinopathy (Del Porto et al., 1993 ) (see also Supplementary Table 3 ). However, the G188R mutation yielded a much milder phenotype, with symptoms of night blindness as late as age 30. Accordingly, visual Weld constriction associated with this genotype was variable. Compared to the R135W mutation, twice as large visual Welds could still be measured in patients at the age of 42 (Fig. 6A) . In the Wrst decade of life, no fundus changes were seen (Del Porto et al., 1993) , patients were asymtomatic, and mixed ERG amplitude was still 50-60% of normal (Figs. 5D and 6B ). Although the waveform and timing of the response of subject V:2 suggest that this b-wave was mainly driven by cone bipolars, and that The plot of normalized amplitude of mixed DA ERG b-wave (expressed as percent of the lowest limit of normal) vs. age for patients with these mutations. The mixed ERGs of patients harboring the R135L mutation remain signiWcantly better preserved than those with the R135W mutation. The overall kinetics of ERG decay deduced from this cross-sectional data appear comparable for the two mutations. However, longitudinal measurements from the R135L proband and two children harboring the R135W mutations (shown encircled) suggest diVerent progression rates vs. baseline between the two mutations: a 25% loss vs. baseline (age 3) was seen over a 7-year period for the R135L proband (on average, 3.5% per year), whereas a 50% loss 1 year from baseline was observed for the two R135W children.
perhaps only the second, abnormally delayed peak reXected rod bipolar activation (see below), this Wnding provides evidence for abnormal and reduced yet persistent and measurable rod-driven activity in children aVected by the G188R mutation.
In subsequent decades, a progressive age-dependent decline of mixed ERG b-wave amplitudes was seen (Fig. 6B) . By age 60, the visual Weld was severely constricted (Fig. 6A) , the mixed ERG of G188R patients was still recordable although reduced to 2% of normal (Fig. 5D) , and good visual acuity was still preserved, in line with the observed preservation of macular integrity documented ophthalmoscopically (see Supplementary Table 3 for further details). The integrity of foveal cones is therefore maintained until late in the course of this form of ADRP. In summary, these features characterize the phenotype associated with the G188R mutation as a class B2 mutant (Cideciyan et al., 1998) . Fig. 5D also shows that subjects harboring the G188R mutation have signiWcantly smaller responses than the subject with the P180A mutation. In addition, the estimated yearly ERG loss progression rate seen in two patients with the G188R mutation was signiWcantly higher (on average, 21.5%) than the 8% observed with the P180A mutation. This correlates well with the regional nature of disease in the latter case. Of relevance to the in vitro and computational data presented later, the observed G188R yearly average rate of disease progression was less than half that of R135W younger patients, but signiWcantly greater than the R135L child followed serially. Hence, in addition to the greater severity from onset of disease associated to codon 135 mutations, this observation also suggests potential for The plot of normalized amplitude of mixed DA ERG b-wave (expressed as percent of the lowest limit of normal) vs. age for patients with RHO mutations P180A and G188R. The mixed ERG of the proband with the P180A mutation is signiWcantly better preserved than that of patients with the G188R mutation, whose response decline is Wt well by an exponential function. The observed average yearly rate of ERG decline deduced from longitudinal observations (encircled data points) was 21.5% for the G188R mutation and 8% for the P180A.
an overall slower progression rate of the disease for patients harboring the G188R mutation compared to those with R135W.
Electroretinographic evidence for anomalous rod-driven responses in patients with class B phenotypes
Subject IV:4 from the P180A pedigree also showed a distinctive splitting of the DA b-wave at ¡0.31 cd s/m 2 stimuli, which is approximately 0.5 log units below the ISCEV standard Xash range (Fig. 5C, arrow) . The second, delayed bwave peak (75 ms) was shown to be genuinely rod-driven by its disappearance when these responses were re-recorded immediately following the LA series and by its progressive re-appearance as DA responses were allowed to recover (illustrated in the Supplementary Wgure). A similar phenomenon was documented also for the asymptomatic child (subject V:2) harboring the G188R mutation in response to a standard mixed Xash of 0.18 cd s/m 2 (also illustrated in the Supplementary Wgure).
It appears reasonable to conclude that this distinctive DA ERG b-wave splitting was consistent with the activity of rod-driven bipolar cells from areas of greater rod disease severity, responding more slowly than the bipolar cells from areas of well preserved rod-(and cone-) mediated activity. Furthermore, not only was the Wrst-and normal in timing-peak diminished at follow up in the P180A proband, but the second delayed b-wave peak was also markedly attenuated at follow-up testing (not shown). This Wnding is suggestive of greater disease progression for rods with initially more severe disease.
Computational studies
The crystal structure of rhodopsin is known (Palczewski et al., 2000) and can thus be used to infer likely eVects of amino acid substitutions on stability based on the local environment of each residue provided by the structure. Two measures of stability were investigated, misfolding and the decay rate of the light-activated, Metarhodopsin II state. Three diVerent algorithms were compared, I-Mutant2.0 (Capriotti et al., 2005) , DFIRE (Zhou & Zhou, 2002) , and FOLDX (Guerois et al., 2002) .
The results of these computations are shown in detail in Supplementary Table 5 . The overall accuracies of all three methods were relatively low. This indicates that the local structure surrounding the mutation site alone is not suYcient to account for the experimentally observed eVects on rhodopsin stability and folding. Usually, this is interpreted as long-range eVects by the mutations, altering the folding or conformation of the protein. To investigate such long-range eVects, we utilized the previously applied FIRST analysis method (Rader et al., 2004) . In this analysis, we found that the core of stability includes several clusters, the largest of which is located surrounding the conserved disulWde bond between residues Cys 110 and Cys 187 lining the retinal binding pocket. The residues of the largest cluster are circled in red in Fig. 1 . The two mutations in the second intradiscal loop, Gly 188 and Pro
180
, are both part of this cluster. It was previously shown that >90% of the residues in this cluster show misfolding upon mutation, indicating a role of this cluster in the folding of rhodopsin (Rader et al., 2004) . Thus, it is highly likely that Gly 188 and Pro 180 mutations will also result in misfolding of rhodopsin. The FIRST simulated unfolding also predicted several other, smaller regions of structural stability. The largest of these is a cluster of residues at the cytoplasmic end of helix 3 and the second cytoplasmic loop, highlighted by blue circles in Fig. 1 . Arg 135 is part of this cluster, strongly suggesting a role of this residue in structural stability of rhodopsin. Mutation at this site would therefore be expected to cause misfolding.
Stability, misfolding, aggregation, and glycosylation of rhodopsin mutants
Expression of the four RHO mutations presented herein by transient transfection in COS-1 cells, reconstitution with 11-cis retinal and puriWcation on 1D4-antibody aYnity chromatography showed that the yield of fully folded, chromophore-containing rhodopsin was low in all four mutants indicating a tendency to misfold in all four cases. Representative absorption spectra of the four mutants and the WT are shown in Fig. 7A . Spectra are normalized to the absorbance at 280 nm (opsin). The ratios between the absorbance at 500 nm as compared to that at 280 nm, a direct measure of the ratio between folded, retinal-bound protein and misfolded protein are summarized in Table 1 . In relative terms to one another, the degree of misfolding varied considerably. The P180A and the R135L mutations caused the least misfolding, whereas G188R and R135W were both severely misfolded. The Wnding that all four mutants cause misfolding is in very good agreement with the predictions by the FIRST method.
Next, we investigated if the folded portions of the mutants diVered in stability. Fig. 7B shows the decrease in 500 nm chromophore at 55°C, an indicator of thermal stability of rhodopsin. WT rhodopsin shows a 10% decrease Fig. 7 . In vitro misfolding, stability, glycosylation, and aggregation state of rhodopsin mutants as compared to wild type. (A) Representative absorbance rhodopsin spectra normalized to the 280 nm absorbance: wild type (black), R135L (teal green), R135W (light green), P180A (red), and G188R (blue). (B) Rhodopsin stability measured by loss of 500 nm chromophore over time at 55°C. Absorbance spectra were measured in time intervals and the decrease in absorbance at 500 nm was expressed as percent of intact structure. (C) Western-blot of wild type (WT) and rhodopsin mutants (R135L, R135W, P180A, and G188R) expressed transiently in COS-1 cells. Protein concentrations were adjusted according to expression level and approximately 0.075 g was loaded. For each mutant or the wild type, equivalent amounts were analyzed before (¡) and after (+) treatment with PNGase F. Table 1 Degrees of misfolding of rhodopsin mutants as compared to wild type a A 280 , opsin absorbance; A 500 , absorbance after retinal binding. Since misfolded rhodopsin does not give rise to 500 nm absorbance peaks, higher ratios are indicative of greater misfolding. Values are the averages obtained for six elution fractions.
A 280 :A 500 absorbance ratio a (means § SD)
Wild type 2.0 § 0.2 R135L 5.6 § 0.3 R135W 10.2 § 1.8 P180A 5.9 § 0.7 G188R 12.7 § 3.0 over a time-course of 13 h. L135R and L135W showed similar but lower stability than wild type, while P180A was highly unstable: within 60 min, greater than 95% of the original chromophore was lost. These results are in good agreement with the stability predictions. We predicted an increase/no change in stability for both R135 mutants, and experimentally observed a behavior similar to wild type rhodopsin, whereas we predicted a highly destabilizing eVect of the P180A mutation, which is what we observed in the experiment. We could not carry out measurements for G188R due to the low expression yields of this mutant. Finally, we compared the SDS-PAGE mobility of the four RHO mutants with the wild type. A Western-blot using the 1D4-antirhodopsin monoclonal antibody is shown in Fig. 7C . First, all four mutants display a markedly diVerent appearance. Normal appearance is a "smear" of a broad band corresponding to heterogeneous glycosylation and monomeric aggregation state, as shown in Fig. 7C in the WT control. The R135L and P180A mutants exhibited a behavior the most similar to wild type, but with increased dimeric and tetrameric conWgurations. In addition, P180A showed degradation products and lesser glycosylation than the wild type and the R135L mutant. Unlike these mutants, R135W and G188R were very diVerent from the wild type. R135W and G188R displayed defects in glycosylation and for R135W much of the protein was aggregated (tetrameric band at 100 kDa). G188R displayed mobility consistent with a strong tendency to dimerize.
Discussion
We have reported the manifestations and the variability in severity and disease progression rates of ADRP associated with RHO sequence changes involving diVerent portions of the rhodopsin molecule (the cytoplasmic edge of H3: R135W and R135L; and the second intradiscal loop: P180A and G188R). We characterized the phenotype of several new families and appraised the phenotype of the two previously reported Italian families within the classiWcation system of Cideciyan et al. (1998) . The G188R mutation is thus added to the list of those classiWed according to this system, supplementing the previously published data (Del Porto et al., 1993) with additional longitudinal observations. Lastly, the availability of data starting from the pediatric age range allowed us to perform a direct comparison since the early stages of disease expression between the R135W (Pannarale et al., 1996) and the R135L mutations. We directly compared the eVects of the four amino acid substitutions on the folding, stability, and glycosylation patterns of rhodopsin by computational predictions and in vitro studies of the rhodopsin mutants.
All residues involved in these four families (Arg 135 , Pro 180 , and Gly
188
) are highly conserved residues in rhodopsins across all species. The four mutations reported here varied with respect to the types of amino acid substitutions. The mutations at codon 135 both lead to a change in size and charge for this residue. The large and basic R amino acid is replaced by a smaller non-polar one in the R135L mutant, and by a non-polar, large and aromatic one in the R135W mutant. The P180A substitution replaces medium size hydrophobic residue (P) with a hydrophobic but smaller (A). Unlike these mutations, G188R leads to the substitution of a small, non-polar amino acid (G) to a large and basic one (R). These diVerences create the premises for diVerent structural and, potentially, phenotypic eVects.
Computational and in vitro analyses correlate with greater disease severity associated with the R135W mutation
The most severe disease (class A) was associated with the mutations at codon 135. This Wnding is consistent with previous independent reports of ADRP associated with mutations aVecting the Arg 135 residue (Jacobson, Kemp, Sung, & Nathans, 1991; Jacobson, Kemp, Cideciyan, & Nathans, 1996; Ponjavic, Abrahamson, Andreasson, Ehinger, & Fex, 1997) . We could successfully document the persistence of recordable ERG responses in children from both the R135W and the R135L family. This data show that ERGs are signiWcantly larger and better preserved over time in subjects with the R135L mutation.
The consistently severe disease associated with these two mutations underscores the functional importance of this residue. The Glu 134 and Arg 135 residues are part of the highly conserved D/E R Y motif at the edge of H3 in the rhodopsin 3D structure (Li, Edwards, Burghammer, Villa, & Schertler, 2004; Palczewski et al., 2000 ) (see Fig. 1 ), an important interaction site with transducin. In vitro studies of bovine rhodopsin mutants have shown that both R135L and R135W bound retinal almost in a wild type-like fashion under the conditions used for reconstitution and puriWcation, but were unable to activate the G protein (Shi et al., 1998) . Prior studies of human rhodopsin had led to the classiWcation of both R135L and R135W as class IIb mutants (Sung et al., 1993) , i.e., defective in their ability to bind 11-cis retinal, folding, and stability, and partial transportation to cell surface. By the criteria used in previous studies, these two mutants did not diVer in their properties. Our computational and in vitro studies support the conclusion that the folding in both of the mutants is severely impaired and show that the predicted misfolding of the R135W mutant is signiWcantly greater than the R135L and that its glycosylation state is the most defective of all four mutants studied. These Wndings provide, at least in part, a potential explanation at the molecular level for the greater disease severity caused by the R135W amino acid substitution.
P180A: Evidence for pathogenicity of this amino acid substitution and rationale for the observed mild disease phenotype
Unlike the above mutations, the two changes aVecting the second intradiscal loop were associated with signiWcantly milder phenotypes. The P180A substitution led to the least severe of the manifestations, with evidence for class B1 behavior in the proband who had a occupational history of high environmental light exposure, and a seemingly mild class B2 phenotype in his mother who did not share this environmental exposure. The potential for class B2 manifestations in association with the P180A mutation appears similar to what has been reported for the P23H-associated phenotype (Cideciyan et al., 1998) . In consideration of the recent evidence that dogs harboring the T4R RHO mutation are exquisitely sensitive to light damage (Cideciyan et al., 2005; Zhu et al., 2004) , the predilection for inferior retinal disease in the proband may reXect a similar predisposition in humans, as already suggested by clinical (Heckenlively, Rodriguez, & Daiger, 1991) and rat (Organisciak, Darrow, Barsalou, Kutty, & Wiggert, 2003; Walsh, van Driel, Lee, & Stone, 2004 ) data for the P23H mutation.
Like in Sohocki et al. (2001) , the P180A change observed in our proband could not be conWrmed by segregation studies in other family members. However, the Pro 180 residue is highly conserved, and it is in the proximity of Glu
181
, a residue that has been reported to cause ADRP likely to result in class A disease (Cideciyan et al., 1998) . Also, in vitro rhodopsin deletion studies have shown that removal of the Pro 180 residue yields a structurally and functionally defective rhodopsin molecule (Doi, Molday, & Khorana, 1990) . Therefore, the introduction of a smaller amino acid, alanine, in place of the wild type proline likely induces a destabilization of the aforementioned network. The pathogenicity of the P180A mutation was strongly corroborated by the computational and in vitro evidence herein provided.
G188R mutation: A rationale for intermediate disease severity
The G188R mutation was associated only with class B2 features, without regional predilection. Our data show that cone function is at least partially maintained for life in patients with this mutation and that there may be room for early rod-speciWc interventions. The in vitro behavior of the G188R mutant has been studied before (Liu, Garriga, & Khorana, 1996; Sung et al., 1991) , conWrming our prediction that this mutant is misfolded (Del Porto et al., 1993) . The mutation at codon 188 introduces a large and basic arginine residue that is likely to preclude the correct folding of the intradiscal portion of the molecule mediated by the formation of a disulWde bond between Cys 187 and Cys 110 (Davidson, Loewen, & Khorana, 1994; Hwa et al., 1999; Karnik, Sakmar, Chen, & Khorana, 1988) . Like Pro
180
, also Gly 188 is part of the folding core predicted by the FIRST method. The in vitro experimental data presented herein show that the G188R mutation causes much more pronounced misfolding than that observed for the P180A mutation.
Although other diVerences are likely to exist in the in vitro behavior of these two mutants, the lesser degree of misfolding of the P180A mutant compared to the G188R correlates well with the milder phenotype associated with the former amino acid change. However, the G188R mutant was as severely misfolded as the R135W, which caused the most severe disease of all in our series. Longitudinal measurements also suggest that the rate of disease progression is about twice as fast in patients with the R135W mutation compared to patients harboring the G188R one. Likewise, the P180A and the R135L mutations were comparable in severity of misfolding, but the latter resulted in a much more severe phenotype. Therefore, misfolding alone is an insuYcient criterion to account for phenotypic diVerences among these four mutants.
One plausible explanation is the known lack of transducin activation by the Arg 135 mutants (Shi et al., 1998) . Thus, in the Arg 135 mutations, misfolding and impairment in signalling function may be acting together to cause a stronger phenotype than the G188R and P180A mutations. It will be an important goal of future studies to characterize the interactions of the G188R and P180A mutants with transducin, arrestin, and rhodopsin kinase, and contrast their properties between themselves and with those of the two Arg 135 mutants. It would also appear important to study these behaviors in the simultaneous presence of WT rhodopsin, since in humans aVected by disease the potential for expression of the WT allele remains, and the extent to which this occurs may be directly correlated to the behavior of the mutant allele. This is a particularly exciting avenue for further research because evidence is mounting that rhodopsin in the ROS is in a dimeric state (reviewed in Palczewski, 2006) and we found preliminary evidence that G188R may have an increased dimer aYnity, providing a possible additional explanation for the less severe phenotype associated with this mutant despite misfolding comparable to R135W.
Conclusions
In summary, we have shown that phenotypic diVerences exist between mutations aVecting the same portion of the molecule. These diVerences pertain to disease severity and progression rates, and in part also to phenotypic classes. A combination of computational folding predictions and in vitro assays allowed us to provide potential explanations for the clinical disease gradient observed for these four mutations (speciWcally, P180A > G188R> R135L> R135W). Caution must always be exerted, however, in drawing in vivo human conclusions from in vitro and animal data. For example, previous in vitro studies could not provide evidence for mislocalization of another mutation presenting with a mixed class B1 and B2 phenotype, P23H. Rhodopsin mutated at this codon mislocalizes to the synaptic terminal of photoreceptors in mice with a human P23H rhodopsin transgene (Roof, Adamian, & Hayes, 1994) but not in mice expressing a murine transgene (Wu et al., 1998) or in Drosophila (Galy, Roux, Sahel, Leveillard, & Giangrande, 2005) . The role of this aberrant localization in disease pathogenesis and progression of this and other forms of RHO-linked ADRP is not well understood.
Recent evidence for a direct and light-independent degenerative eVect of mislocalized rhodopsin has been provided in Xenopus laevis retinas harboring a C-terminus mutant equivalent to the Q344X human counterpart (Tam, Xie, Oprian, & Moritz, 2006) . Recent in vitro data also suggest that the P23H mutant may result in formation of aggresomes and generalized impairment of the ubiquitin proteasome system (Illing, Rajan, Bence, & Kopito, 2002; Saliba, Munro, Luthert, & Cheetham, 2002) . Therefore, the in vivo intracellular fate of mutant rhodopsin molecules may also be a very important variable to characterize to fully appreciate the consequences and mechanism(s) of disease linked to RHO mutations.
IdentiWcation and characterization of RHO mutations remains important because it continues to improve our understanding of RP pathophysiology and yields clinically important prognostic information. The combined use of clinical and functional data with computational and in vitro expression experiments show promise as an approach to improve further the understanding of RP caused by RHO mutations and test hypotheses that each approach, when used alone, cannot address eVectively.
